Cancer BiologybioRxiv
Cell line-specific network models of ER+ breast cancer identify PI3Kα inhibitor sensitivity factors and drug combinations
DOI 10.1158/0008-5472.can-21-1208
Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
3 papers
Recent·Most cited
C. A. Painter, E. Jain, B. N. Tomson…·N. Wagle
The paper describes the Angiosarcoma Project, a patient-partnered initiative that generates genomic data on angiosarcoma, identifying recurrent mutations and potential therapeutic targets.
J. Gomez Tejeda Zanudo, R. Albert
The paper develops a network model of breast cancer signaling to identify drug resistance mechanisms and predict effective combinatorial treatments.